SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-244196
Filing Date
2020-09-11
Accepted
2020-09-11 16:47:56
Documents
19
Period of Report
2020-09-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d94329d8k.htm   iXBRL 8-K 29823
2 EX-1.1 d94329dex11.htm EX-1.1 200905
3 EX-5.1 d94329dex51.htm EX-5.1 10223
4 EX-99.1 d94329dex991.htm EX-99.1 4975
5 EX-99.2 d94329dex992.htm EX-99.2 9494
9 GRAPHIC g94329dsp41.jpg GRAPHIC 2277
10 GRAPHIC g94329dsp42left.jpg GRAPHIC 8376
11 GRAPHIC g94329dsp42right.jpg GRAPHIC 1161
  Complete submission text file 0001193125-20-244196.txt   449429

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA itci-20200910.xsd EX-101.SCH 3112
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20200910_lab.xml EX-101.LAB 17374
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20200910_pre.xml EX-101.PRE 10981
12 EXTRACTED XBRL INSTANCE DOCUMENT d94329d8k_htm.xml XML 3214
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 201171448
SIC: 2834 Pharmaceutical Preparations